US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

CADL holding history

Candel Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CADL overview All 13F holders of CADL Full Q2 2026 holdings

Shares (Q2 2026): 699
Value: $7.20K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2025

Holdings of CADL by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	699	$7.20K	<0.1%	−32−4.4%	Reduced	Holders
Q1 2026	731	$3.58K	<0.1%	+731	New	Holders
Q2 2025	0	$0	0.0%	−416−100.0%	Sold out	Holders
Q1 2025	416	$2.35K	<0.1%	+416	New	Holders